First Time Loading...

Medadvisor Ltd
ASX:MDR

Watchlist Manager
Medadvisor Ltd Logo
Medadvisor Ltd
ASX:MDR
Watchlist
Price: 0.295 AUD -3.28% Market Closed
Updated: Apr 27, 2024

Wall Street
Price Targets

MDR Price Targets Summary
Medadvisor Ltd

Wall Street analysts forecast MDR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDR is 0.411 AUD with a low forecast of 0.384 AUD and a high forecast of 0.462 AUD.

Lowest
Price Target
0.384 AUD
30% Upside
Average
Price Target
0.411 AUD
39% Upside
Highest
Price Target
0.462 AUD
57% Upside
Medadvisor Ltd Competitors:
Price Targets
HSTM
HealthStream Inc
26% Upside
CONTX
ContextVision AB
28% Upside
CARA
Carasent ASA
82% Upside
GPI
GPI SpA
22% Upside
SECT B
Sectra AB
32% Downside
SDGR
Schrodinger Inc
60% Upside
AUGX
Augmedix Inc
117% Upside
ICAD
ICAD Inc
235% Upside

Revenue
Forecast

Revenue Estimate
Medadvisor Ltd

For the last 8 years the compound annual growth rate for Medadvisor Ltd's revenue is 70%. The projected CAGR for the next 3 years is 13%.

70%
Past Growth
13%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Medadvisor Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Medadvisor Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MDR's stock price target?
Price Target
0.411 AUD

According to Wall Street analysts, the average 1-year price target for MDR is 0.411 AUD with a low forecast of 0.384 AUD and a high forecast of 0.462 AUD.

What is Medadvisor Ltd's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Medadvisor Ltd's revenue is 70%. The projected CAGR for the next 3 years is 13%.